Request for Covid-19 Impact Assessment of this Report

Materials and Chemicals

United States Carbidopa Market Report 2017

  • QYR934189
  • 120 Pages
  • February 2017
  • Materials and Chemicals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Carbidopa

Revenue, means the sales value of Carbidopa

This report studies sales (consumption) of Carbidopa in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Novartis

Merck Sharp & Dohme

AbbVie

Impax

WOCKHARDT

Allergan

Teva Pharmaceuticals

Mylan N.V.

Valeant

Jinghua Pharmaceutical

Market Segment by States, covering

California

Texas

New York

Florida

Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Type I

Type II

Split by applications, this report focuses on sales, market share and growth rate of Carbidopa in each application, can be divided into

Application 1

Application 2

Table of Contents

United States Carbidopa Market Report 2017

1 Carbidopa Overview

1.1 Product Overview and Scope of Carbidopa

1.2 Classification of Carbidopa

1.2.1 Type I

1.2.2 Type II

1.3 Application of Carbidopa

1.3.1 Application 1

1.3.2 Application 2

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Carbidopa (2012-2022)

1.4.1 United States Carbidopa Sales and Growth Rate (2012-2022)

1.4.2 United States Carbidopa Revenue and Growth Rate (2012-2022)

2 United States Carbidopa Competition by Manufacturers

2.1 United States Carbidopa Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Carbidopa Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Carbidopa Average Price by Manufactures (2015 and 2016)

2.4 Carbidopa Market Competitive Situation and Trends

2.4.1 Carbidopa Market Concentration Rate

2.4.2 Carbidopa Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Carbidopa Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Carbidopa Sales and Market Share by States (2012-2017)

3.2 United States Carbidopa Revenue and Market Share by States (2012-2017)

3.3 United States Carbidopa Price by States (2012-2017)

4 United States Carbidopa Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Carbidopa Sales and Market Share by Type (2012-2017)

4.2 United States Carbidopa Revenue and Market Share by Type (2012-2017)

4.3 United States Carbidopa Price by Type (2012-2017)

4.4 United States Carbidopa Sales Growth Rate by Type (2012-2017)

5 United States Carbidopa Sales (Volume) by Application (2012-2017)

5.1 United States Carbidopa Sales and Market Share by Application (2012-2017)

5.2 United States Carbidopa Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Carbidopa Manufacturers Profiles/Analysis

6.1 Novartis

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Carbidopa Product Type, Application and Specification

6.1.2.1

6.1.2.2

6.1.3 Novartis Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Merck Sharp & Dohme

6.2.2 Carbidopa Product Type, Application and Specification

6.2.2.1

6.2.2.2

6.2.3 Merck Sharp & Dohme Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 AbbVie

6.3.2 Carbidopa Product Type, Application and Specification

6.3.2.1

6.3.2.2

6.3.3 AbbVie Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Impax

6.4.2 Carbidopa Product Type, Application and Specification

6.4.2.1

6.4.2.2

6.4.3 Impax Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 WOCKHARDT

6.5.2 Carbidopa Product Type, Application and Specification

6.5.2.1

6.5.2.2

6.5.3 WOCKHARDT Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Allergan

6.6.2 Carbidopa Product Type, Application and Specification

6.6.2.1

6.6.2.2

6.6.3 Allergan Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Teva Pharmaceuticals

6.7.2 Carbidopa Product Type, Application and Specification

6.7.2.1

6.7.2.2

6.7.3 Teva Pharmaceuticals Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Mylan N.V.

6.8.2 Carbidopa Product Type, Application and Specification

6.8.2.1

6.8.2.2

6.8.3 Mylan N.V. Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Valeant

6.9.2 Carbidopa Product Type, Application and Specification

6.9.2.1

6.9.2.2

6.9.3 Valeant Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Jinghua Pharmaceutical

6.10.2 Carbidopa Product Type, Application and Specification

6.10.2.1

6.10.2.2

6.10.3 Jinghua Pharmaceutical Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

7 Carbidopa Manufacturing Cost Analysis

7.1 Carbidopa Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Carbidopa

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Carbidopa Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Carbidopa Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Carbidopa Market Forecast (2017-2022)

11.1 United States Carbidopa Sales, Revenue Forecast (2017-2022)

11.2 United States Carbidopa Sales Forecast by Type (2017-2022)

11.3 United States Carbidopa Sales Forecast by Application (2017-2022)

11.4 Carbidopa Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

List of Tables and Figures

Figure Picture of Carbidopa

Table Classification of Carbidopa

Figure United States Sales Market Share of Carbidopa by Type in 2015

Table Application of Carbidopa

Figure United States Sales Market Share of Carbidopa by Application in 2015

Figure United States Carbidopa Sales and Growth Rate (2012-2022)

Figure United States Carbidopa Revenue and Growth Rate (2012-2022)

Table United States Carbidopa Sales of Key Manufacturers (2015 and 2016)

Table United States Carbidopa Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Carbidopa Sales Share by Manufacturers

Figure 2016 Carbidopa Sales Share by Manufacturers

Table United States Carbidopa Revenue by Manufacturers (2015 and 2016)

Table United States Carbidopa Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Carbidopa Revenue Share by Manufacturers

Table 2016 United States Carbidopa Revenue Share by Manufacturers

Table United States Market Carbidopa Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Carbidopa Average Price of Key Manufacturers in 2015

Figure Carbidopa Market Share of Top 3 Manufacturers

Figure Carbidopa Market Share of Top 5 Manufacturers

Table United States Carbidopa Sales by States (2012-2017)

Table United States Carbidopa Sales Share by States (2012-2017)

Figure United States Carbidopa Sales Market Share by States in 2015

Table United States Carbidopa Revenue and Market Share by States (2012-2017)

Table United States Carbidopa Revenue Share by States (2012-2017)

Figure Revenue Market Share of Carbidopa by States (2012-2017)

Table United States Carbidopa Price by States (2012-2017)

Table United States Carbidopa Sales by Type (2012-2017)

Table United States Carbidopa Sales Share by Type (2012-2017)

Figure United States Carbidopa Sales Market Share by Type in 2015

Table United States Carbidopa Revenue and Market Share by Type (2012-2017)

Table United States Carbidopa Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Carbidopa by Type (2012-2017)

Table United States Carbidopa Price by Type (2012-2017)

Figure United States Carbidopa Sales Growth Rate by Type (2012-2017)

Table United States Carbidopa Sales by Application (2012-2017)

Table United States Carbidopa Sales Market Share by Application (2012-2017)

Figure United States Carbidopa Sales Market Share by Application in 2015

Table United States Carbidopa Sales Growth Rate by Application (2012-2017)

Figure United States Carbidopa Sales Growth Rate by Application (2012-2017)

Table Novartis Basic Information List

Table Novartis Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

Figure Novartis Carbidopa Sales Market Share (2012-2017)

Table Merck Sharp & Dohme Basic Information List

Table Merck Sharp & Dohme Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

Table Merck Sharp & Dohme Carbidopa Sales Market Share (2012-2017)

Table AbbVie Basic Information List

Table AbbVie Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

Table AbbVie Carbidopa Sales Market Share (2012-2017)

Table Impax Basic Information List

Table Impax Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

Table Impax Carbidopa Sales Market Share (2012-2017)

Table WOCKHARDT Basic Information List

Table WOCKHARDT Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

Table WOCKHARDT Carbidopa Sales Market Share (2012-2017)

Table Allergan Basic Information List

Table Allergan Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

Table Allergan Carbidopa Sales Market Share (2012-2017)

Table Teva Pharmaceuticals Basic Information List

Table Teva Pharmaceuticals Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

Table Teva Pharmaceuticals Carbidopa Sales Market Share (2012-2017)

Table Mylan N.V. Basic Information List

Table Mylan N.V. Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

Table Mylan N.V. Carbidopa Sales Market Share (2012-2017)

Table Valeant Basic Information List

Table Valeant Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

Table Valeant Carbidopa Sales Market Share (2012-2017)

Table Jinghua Pharmaceutical Basic Information List

Table Jinghua Pharmaceutical Carbidopa Sales, Revenue, Price and Gross Margin (2012-2017)

Table Jinghua Pharmaceutical Carbidopa Sales Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Carbidopa

Figure Manufacturing Process Analysis of Carbidopa

Figure Carbidopa Industrial Chain Analysis

Table Raw Materials Sources of Carbidopa Major Manufacturers in 2015

Table Major Buyers of Carbidopa

Table Distributors/Traders List

Figure United States Carbidopa Production and Growth Rate Forecast (2017-2022)

Figure United States Carbidopa Revenue and Growth Rate Forecast (2017-2022)

Table United States Carbidopa Production Forecast by Type (2017-2022)

Table United States Carbidopa Consumption Forecast by Application (2017-2022)

Table United States Carbidopa Sales Forecast by States (2017-2022)

Table United States Carbidopa Sales Share Forecast by States (2017-2022)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Global Photonic Crystals Market (Construction Strategies, Geography , Applications) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Photonic Crystals are attractive optical materials for controlling and manipulating the flow of light. The global market for components and modules using Photonic Crystals indicates a CAGR of 33.1% and is estimated to reach $20.4 billion in 2017.

  • Publish Date: February 8, 2017
  • $5370
Molded Plastics Market by Product (Polyvinyl Chloride, Polypropylene, Polystyrene, Low Density Polyethylene, High Density Polyethylene, Polyethylene Terephthalate, and Engineering Plastics), Technology (Injection Molding, Blow Molding, Extrusion, and Others), and Application (Building & Construction, Electrical & Electronics, Automotive and Packaging) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Global molded plastics market was valued at $529,845 million in 2016, and is expected to garner $690,158 million by 2023, registering a CAGR of 3.9% from 2017 to 2023. Molded plastics are synthetically produced non-metallic compounds, which can be molded ...

  • Publish Date: July 4, 2017
  • $5370